Your browser doesn't support javascript.
loading
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma.
Jones, Martin R; Williamson, Laura M; Topham, James T; Lee, Michael K C; Goytain, Angela; Ho, Julie; Denroche, Robert E; Jang, GunHo; Pleasance, Erin; Shen, Yaoquing; Karasinska, Joanna M; McGhie, John P; Gill, Sharlene; Lim, Howard J; Moore, Malcolm J; Wong, Hui-Li; Ng, Tony; Yip, Stephen; Zhang, Wei; Sadeghi, Sara; Reisle, Carolyn; Mungall, Andrew J; Mungall, Karen L; Moore, Richard A; Ma, Yussanne; Knox, Jennifer J; Gallinger, Steven; Laskin, Janessa; Marra, Marco A; Schaeffer, David F; Jones, Steven J M; Renouf, Daniel J.
Afiliação
  • Jones MR; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Williamson LM; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Topham JT; Pancreas Centre British Columbia, Vancouver, Canada.
  • Lee MKC; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Goytain A; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Ho J; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Denroche RE; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Jang G; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Pleasance E; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Shen Y; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Karasinska JM; Pancreas Centre British Columbia, Vancouver, Canada.
  • McGhie JP; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Gill S; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Lim HJ; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Moore MJ; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Wong HL; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Ng T; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Yip S; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Zhang W; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Sadeghi S; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Reisle C; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Mungall AJ; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Mungall KL; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Moore RA; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Ma Y; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Knox JJ; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Gallinger S; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Laskin J; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Marra MA; Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Schaeffer DF; BC Cancer, Division of Medical Oncology, Vancouver, British Columbia, Canada.
  • Jones SJM; BC Cancer, Canada's Michael Smith Genome Sciences Centre, Vancouver, British Columbia, Canada.
  • Renouf DJ; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Clin Cancer Res ; 25(15): 4674-4681, 2019 Aug 01.
Article em En | MEDLINE | ID: mdl-31068372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article